Blood-Based Signature Predicts Levels of Amyloid in CSF
March 14th 2019The research staff member at the IBM Research-Australia lab discussed how he and colleagues utilized machine learning to identify a set of proteins in blood that can predict the concentration of amyloid-beta in spinal fluid.
Head of NCI Ned Sharpless Named Acting FDA Commissioner
March 13th 2019Ned Sharpless, MD, the director of the National Cancer Institute, has been named to the position of acting FDA Commissioner. The announcement was made just a week after the current commissioner, Scott Gottlieb, MD, announced his plans to resign in early April.
Dina Katabi, PhD: Biosensors for Measuring Disease Activity in MS and Other Neurological Disorders
March 13th 2019The Andrew & Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT spoke about a new way of continuous monitoring for patients with MS and neurodegenerative disorders, discovering changes in quality of life and new biomarkers.
Assessing the Value MS Centers Provide to Patients and Institutions
March 11th 2019The chief of the Multiple Sclerosis Division at the Perelman School of Medicine discussed the importance of institutions recognizing the value a comprehensive MS clinic can provide not only to the patients but the institution itself.
Fred Lublin, MD: Current Challenges in MS
March 11th 2019The director of the Corinne Goldsmith Dickinson Center for MS at Mount Sinai School of Medicine spoke about the major issues in MS right now: being able to individually prognosticate, moving toward developing better therapies for a progressive disease, and repairing the damage to the nervous system.